Karim Fizazi
MD, PhD
Professor of Medicine, Department of Cancer Medicine
👥Biography 个人简介
Karim Fizazi is a distinguished genitourinary oncologist and co-investigator of the ARAMIS trial establishing darolutamide for nmCRPC. He has contributed seminal research on skeletal-related events, bone-targeted therapies, and novel hormonal therapies across the castration-resistant prostate cancer spectrum. His work on the LATITUDE and ARAMIS trials has fundamentally altered treatment pathways for both hormone-sensitive and non-metastatic CRPC. Fizazi is one of the most prolific and cited investigators in prostate cancer globally.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Karim Fizazi 的研究动态
Follow Karim Fizazi's research updates
留下邮箱，当我们发布与 Karim Fizazi（Institut Gustave Roussy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment